Five Years of Nucleate: Empowering the Next Generation of Biotech Entrepreneurs
Nucleate, a nonprofit organization dedicated to fostering the next generation of biotech leaders, has unveiled its inaugural impact report. Over five years, Nucleate has scaled from a student-led program at the Harvard Biotech Club to a global 501(c)(3) non-profit with 41 chapters operating internationally across 20+ countries. This report showcases the remarkable work the organization and its volunteers has achieved over the course of five years.
October 16, 2024
| BioBuzz has been connecting the life science workforce since 2009. We’ve built an expansive community in the Mid-Atlantic with a national readership that spans from Massachusettes to Florida, and New York to California. For our next chapter, we’re building a proprietary talent logistics model to help employers source and hire life science talent. Learn more. |
Nucleate’s keystone program, the Activator, is a six-month, equity-free educational program designed for academic trainee-led biotech founders. Several groundbreaking companies have emerged from the Nucleate Activator, securing millions in funding and making strides in biotech innovation, some of which are:
- NextRNA Therapeutics raised $56 million in venture capital to develop therapeutics targeting non-coding RNAs.
- Manifold Bio secured $45 million as a company focused on protein design technologies and developing biologics.
- Concerto Biosciences raised $26 million to develop microbial therapies.
- Glyphic Biotechnologies raised over $44 million and is pioneering next-generation protein sequencing technologies.
“As we celebrate our growth, we reaffirm our commitment to addressing unmet needs in the biotech landscape,” stated Soufiane Aboulhouda, Co-founder and Chairman of the Board. “This report not only reflects our achievements but marks the beginning of a broader journey.”
The organization, which expanded its reach to Washington, D.C., and Baltimore in 2021, further highlights the success of the regional Activator Program. Recent regional alumni ventures including Aptabridge Therapeutics, Prompt Diagnostics, CurveAssure, and Somnair. Post Activator program these startups have gone on to participate in the LifeBridge Health BioIncubator, the Activate Fellowship, and Rice Business Plan Competition. Together, regional alumni companies have raised over >$3 million in venture and grant funding. We are grateful for the Blackbird Labs sponsorship in helping our regional programming flourish.
As we highlight the work of our program, we invite interested candidates to join the coming 2024-2025 Activator. We welcome interested candidates (PhDs, MDs, Post-Docs, MBAs, & MS students) to apply to the Nucleate program. For more details, please reach out to [email protected]. Apply via the following portal by Nov. 6th, 2024 (extended from Oct. 15th). For interested industry mentors and experts who would like to get involved in our invited workshop series, please fill out our interest form.
Click to access the Nucleate Flagship 5-year report and for more information, visit nucleate.org or reach out via email at [email protected].
Nucleate’s programs are made possible thanks to our generous sponsors:
Platinum: Eli Lilly and Company, Genentech, Pillar VC, Alnylam Pharmaceuticals, BlueYard Capital, MilliporeSigma (HQ), Blackbird Labs (Regional)
Gold: Excedr (HQ)
Silver: Biocom California, Breakout Ventures, Schrödinger, Cromatic, Sanofi, PHCbi, Molecule (HQ)
Philanthropic: Schmidt Futures, Lyda Hill Philanthropies (HQ), Whiteford Taylor & Preston LLP (Regional)
Regional Partners: Johns Hopkins Pava Center for Entrepreneurship, Biobuzz Media, Hopstone Captial, and UM Ventures
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
